MINERALYS THERAPEUTICS INC. - COMMON STOCK

9.1200

14-January-25 16:45:00

15 minutes delayed

Stocks

-0.2400

-2.56%

Today's range

8.9000 - 9.3900

ISIN

N/A

Source

NASDAQ

Mineralys Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference on Wednesday, May 10, 2023

27 Apr 2023 16:47:56 By Nasdaq GlobeNewswire
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

15 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC.23/WCC

04 Mar 2023 16:30:00 By Nasdaq GlobeNewswire
Mineralys Therapeutics to Announce Fourth Quarter 2022 Financial Results and Host Conference Call on Wednesday, March 15, 2023

01 Mar 2023 16:05:01 By Nasdaq GlobeNewswire
Mineralys Therapeutics Abstracts Selected to be Presented at the American College of Cardiology Annual Scientific Session & Expo Together with the World Congress of Cardiology (ACC.23/WCC) in March 2023

20 Feb 2023 08:00:00 By Nasdaq GlobeNewswire
Mineralys Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

14 Feb 2023 16:01:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.